-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P0csOVCrsp9DJA1+xdxFyrLf/kxIm7OoLZk5LJtCPsIycSjuQmq04D+hBX42eoDv 0JG92Xm4URH349Vlkb7jEQ== 0001181431-05-016984.txt : 20050315 0001181431-05-016984.hdr.sgml : 20050315 20050315195611 ACCESSION NUMBER: 0001181431-05-016984 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20050311 FILED AS OF DATE: 20050315 DATE AS OF CHANGE: 20050315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAVAS PETER G CENTRAL INDEX KEY: 0001127426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-06533 FILM NUMBER: 05683161 BUSINESS ADDRESS: STREET 1: 110 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02173 BUSINESS PHONE: 6178624003 MAIL ADDRESS: STREET 1: 110 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02173 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON LIFE SCIENCES INC /DE CENTRAL INDEX KEY: 0000094784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870277826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 NEWBURY STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174250200 MAIL ADDRESS: STREET 1: 20 NEWBURY STREET STREET 2: 5TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: GREENWICH PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: STRATEGIC MEDICAL RESEARCH CORP /DE DATE OF NAME CHANGE: 19790521 4 1 rrd72627.xml FORM 4 X0202 4 2005-03-11 0 0000094784 BOSTON LIFE SCIENCES INC /DE BLSI 0001127426 SAVAS PETER G 20 NEWBURY STREET BOSTON MA 02116 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 2.31 2005-03-11 4 A 0 64471 2.31 A 2015-03-10 Common Stock 64471 464471 D Stock Option (Right to Buy) 2.31 2005-03-11 4 A 0 135529 2.31 A 2015-03-10 Common Stock 135529 600000 D Options to purchase 64,471 shares of common stock were granted under the Company's Amended and Restated Omnibus Stock Option Plan and 135,529 shares of common stock were granted under the Company's 1998 Omnibus Stock Option Plan. The options are 33% exercisable as of March 11, 2005, and thereafter in 36 equal monthly installments. Includes multiple option grants with different exercise prices and vesting dates. /s/ Peter G. Savas 2005-03-15 -----END PRIVACY-ENHANCED MESSAGE-----